Group 1 - The latest stock price of Lizhu Group is 40.10 yuan, an increase of 1.13% compared to the previous trading day, with a trading volume of 4.24 billion yuan [1] - Lizhu Group is primarily engaged in the research, production, and sales of pharmaceutical products, covering areas such as chemical preparations, active pharmaceutical ingredients, diagnostic reagents, and equipment [1] - On August 15, Lizhu Group announced that its research and development application for the drug JP-1366 has been accepted by the National Medical Products Administration, targeting gastroesophageal reflux disease [1] Group 2 - The cumulative R&D investment for the drug JP-1366 has reached 185 million yuan [1] - On the same day, the net inflow of main funds into Lizhu Group was 39.34 million yuan, with a net inflow of 20.07 million yuan over the past five days [1]
丽珠集团股价上涨1.13% 创新药JP-1366片注册申请获受理